Stay updated on T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The date has been updated from October 9, 2024, to May 9, 2025.
    Difference
    0.6%
    Check dated 2025-05-14T19:51:55.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:46:54.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.
    Difference
    1.0%
    Check dated 2025-04-16T01:37:03.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T20:06:36.000Z thumbnail image
  6. Check
    86 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:12:11.000Z thumbnail image
  7. Check
    107 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:29:33.000Z thumbnail image

Stay in the know with updates to T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.